U.S agencies and Indian authorities are working together to stop fentanyl before it enters the American market.
The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...
Hosted on MSN
India needs an FDA-style drug regulator — Now
It's hard to stomach the latest news—twentysix children dead across Madhya Pradesh and Rajasthan, because of cough syrup poisoning. The culprit: Coldrif, a syrup made by Sresan Pharmaceuticals, tested ...
The United States and India launched the first meeting of their joint drug policy working group in Washington last week.
The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory ...
WASHINGTON, DC – US lawmakers renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid-19 pandemic by India ...
As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...
India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...
As the Nipah cases in India raise worries across Asia, a new study by Chinese researchers has claimed that an existing oral ...
RANCHI: The Union Ministry of Home Affairs (MHA) on Wednesday announced an ambitious target to make India drug-free by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results